Savitra Medicos Profile
Key Indicators
- Authorised Capital ₹ 4.20 M
- Paid Up Capital ₹ 3.99 M
- Company Age 21 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 1.60 Cr
- Revenue Growth 10.76%
- Profit Growth 103.31%
- Ebitda 284.10%
- Net Worth -0.57%
- Total Assets -17.42%
About Savitra Medicos
Savitra Medicos Private Limited (SMPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 November 2003 and has a history of 21 years and three months. Its registered office is in Punjab, Punjab.
The Company is engaged in the Pharmaceuticals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.20 M and a paid-up capital of Rs 3.99 M.
The company currently has active open charges totaling ₹1.60 Cr.
Sanjeev Kumar and Rakesh Bagga serve as directors at the Company.
Company Details
-
LocationPunjab, Punjab
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U18100PB2003PTC026516
-
Company No.
026516
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Nov 2003
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Savitra Medicos?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rakesh Bagga
|
Managing Director | 07-Nov-2003 | Current |
Board Members (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Sanjeev Kumar
|
Director | 25-Feb-2010 | Current |
Financial Performance of Savitra Medicos.
Savitra Medicos Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 10.76% increase. The company also saw a substantial improvement in profitability, with a 103.31% increase in profit. The company's net worth dipped by a decrease of 0.57%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Savitra Medicos?
In 2017, Savitra Medicos had a promoter holding of 99.67% and a public holding of 0.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹16.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 1.60 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 24 Dec 2003 | State Bank Of India | ₹1.60 Cr | Open |
How Many Employees Work at Savitra Medicos?
Unlock and access historical data on people associated with Savitra Medicos, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Savitra Medicos, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Savitra Medicos's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
